Tabacof Laura, Chiplunkar Maanas, Canori Alexandra, Howard Rebecca, Wood Jamie, Proal Amy, Putrino David
Cohen Center for Recovery from Complex Chronic Illness, Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Rusk Rehabilitation, Department of Physical Medicine and Rehabilitation, New York University Grossman School of Medicine, New York, NY, United States.
Front Rehabil Sci. 2024 Oct 18;5:1448816. doi: 10.3389/fresc.2024.1448816. eCollection 2024.
BACKGROUND: For many people with long COVID (LC), new-onset pain is a debilitating consequence. This study examined the nature of new-onset pain and concomitant symptoms in patients with LC to infer mechanisms of pain from the relationships between pain and health-related factors. METHODS: Pain and other symptoms were evaluated in 153 individuals with LC using the Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs, EuroQoL Visual Analog Scale, and Quality of Life in Neurological Disorders. The relationships between pain and patient factors were analyzed using Chi Square and independent -tests. RESULTS: 20.3% of individuals who reported new-onset pain had neuropathic pain, which was associated with lower quality of life and higher rates of cognitive dysfunction compared to those with non-neuropathic pain. Other symptoms were similar between groups, however heart-related symptoms were more prevalent in individuals with neuropathic pain and mood swings were more prevalent for individuals with non-neuropathic pain. CONCLUSIONS: Characterizing the relationships between NP and quality of life in individuals with LC can aid in developing better clinical management strategies. Understanding the associations between NP and cognitive dysfunction provides the imperative foundation for future studies further examining the pathophysiological mechanisms underlying pain development in LC.
Front Rehabil Sci. 2024-10-18
Br J Sports Med. 2013-1
Cochrane Database Syst Rev. 2019-7-5
Diagnostics (Basel). 2022-6-24
Open Forum Infect Dis. 2024-3-6
Nat Immunol. 2023-10
Lancet Infect Dis. 2023-4
J Clin Med. 2023-2-20
J Clin Med. 2022-9-22